|College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer|
AC Wolff, ME Hammond, JN Schwartz, KL Hagerty, DC Allred, RJ Cote, ...
J clin oncol 25 (1), 118-145, 2007
|College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer|
ME Hammond, DF Hayes, M Dowsett, DC Allred, KL Hagerty, S Badve, ...
J Clin Oncol 28 (16), 2784-2795, 2010
|Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice …|
AC Wolff, MEH Hammond, DG Hicks, M Dowsett, LM McShane, ...
Archives of Pathology and Laboratory Medicine 138 (2), 241-256, 2014
|American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer|
GH Lyman, AE Giuliano, MR Somerfield, AB Benson, DC Bodurka, ...
Journal of clinical oncology 23 (30), 7703-7720, 2005
|2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline|
TJ Smith, J Khatcheressian, GH Lyman, H Ozer, JO Armitage, L Balducci, ...
J Clin Oncol 24 (19), 3187-3205, 2006
|American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor–positive …|
EP Winer, C Hudis, HJ Burstein, AC Wolff, KI Pritchard, JN Ingle, ...
Journal of clinical oncology 23 (3), 619-629, 2005
|Weekly paclitaxel in the adjuvant treatment of breast cancer|
JA Sparano, M Wang, S Martino, V Jones, EA Perez, T Saphner, AC Wolff, ...
New England Journal of Medicine 358 (16), 1663-1671, 2008
|Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199|
S Adams, RJ Gray, S Demaria, L Goldstein, EA Perez, LN Shulman, ...
Journal of clinical oncology 32 (27), 2959, 2014
|Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis|
BB Barone, HC Yeh, CF Snyder, KS Peairs, KB Stein, RL Derr, AC Wolff, ...
Jama 300 (23), 2754-2764, 2008
|Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update|
AC Wolff, MEH Hammond, KH Allison, BE Harvey, PB Mangu, ...
Archives of pathology & laboratory medicine 142 (11), 1364-1382, 2018
|American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting|
JLWAC Khatcheressian, TJGE Smith, HBVVG Muss, FSMR Halberg, ...
Journal of Clinical Oncology 24 (31), 5091-5097, 2006
|Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane|
HJ Burstein, AD Elias, HS Rugo, MA Cobleigh, AC Wolff, PD Eisenberg, ...
Journal of Clinical Oncology 26 (11), 1810-1816, 2008
|Adjuvant chemotherapy in older women with early-stage breast cancer|
HB Muss, DA Berry, CT Cirrincione, M Theodoulou, AM Mauer, ...
New England Journal of Medicine 360 (20), 2055-2065, 2009
|Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update|
JL Khatcheressian, P Hurley, E Bantug, LJ Esserman, E Grunfeld, ...
J Clin Oncol [internet], 2012
RW Carlson, DC Allred, BO Anderson, HJ Burstein, WB Carter, SB Edge, ...
Journal of the National Comprehensive Cancer Network 7 (2), 122-192, 2009
|Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer|
SM Tolaney, WT Barry, CT Dang, DA Yardley, B Moy, PK Marcom, ...
New England Journal of Medicine 372 (2), 134-141, 2015
|TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer|
LA Carey, HS Rugo, PK Marcom, EL Mayer, FJ Esteva, CX Ma, MC Liu, ...
Journal of clinical oncology 30 (21), 2615, 2012
|Extending aromatase-inhibitor adjuvant therapy to 10 years|
PE Goss, JN Ingle, KI Pritchard, NJ Robert, H Muss, J Gralow, K Gelmon, ...
N Engl J Med 375, 209-219, 2016
|Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis|
KS Peairs, BB Barone, CF Snyder, HC Yeh, KB Stein, RL Derr, ...
Journal of Clinical Oncology 29 (1), 40, 2011
|Detection of cancer DNA in plasma of patients with early-stage breast cancer|
JA Beaver, D Jelovac, S Balukrishna, RL Cochran, S Croessmann, ...
Clinical cancer research 20 (10), 2643-2650, 2014